宫癌中的miRNA:诊断到治疗:系统性审查

Hiwot Tezera Endale1, Yitbarek Fantahun Mariye2, Habtu Kifle Negash3

  • 1Department of Biochemistry, School of Medicine, College of Medicine & Health Sciences, University of Gondar, Ethiopia.

Heliyon
|February 6, 2024
PubMed
概括

微RNAs (miRNAs) 是宫癌 (CC) 发展中的关键表观遗传参与者. 本综述探讨了CC进展中的miRNA配置文件,强调它们作为诊断生物标志物和治疗点的潜力.